International Ophthalmology

, Volume 38, Issue 6, pp 2371–2379 | Cite as

The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma

  • Faisal A. AlmobarakEmail author
  • Ali H. Alharbi
  • Jose Morales
  • Ibrahim Aljadaan
Original Paper



To evaluate the influence of mitomycin C (MMC) concentration on the outcome of trabeculectomy in uveitic glaucoma.


Retrospective comparative study included 50 patients who underwent MMC-enhanced trabeculectomy for uncontrolled uveitic glaucoma. Patients were divided into two groups based on the concentration of MMC used during trabeculectomy (high [0.04%] or low [0.02%]). The main outcome measures were: the intraocular pressure (IOP), the number of antiglaucoma medications, the need for further glaucoma surgeries, and trabeculectomy success.


There were no differences in the IOP nor antiglaucoma medications. The success rates were 76.0 and 68.0%, while the failure rates were 24.0 and 32.0% in the 0.02 and 0.04% MMC groups, respectively.


Trabeculectomy augmented with low (0.02%) MMC concentration seems to have comparable outcomes in uveitic glaucoma compared with high (0.04%) concentration.


Glaucoma Mitomycin C Outcome Trabeculectomy Uveitis 



This work was supported by College of Medicine Research Center. Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Panek WC, Holland GN, Lee DA et al (1990) Glaucoma in patients with uveitis. Br J Ophthalmol 74(4):223–227CrossRefGoogle Scholar
  2. 2.
    Noble J, Derzko-Dzulynsky L, Rabinovitch T et al (2007) Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol 42(1):89–94CrossRefGoogle Scholar
  3. 3.
    Dupas B, Fardeau C, Cassoux N et al (2010) Deep sclerectomy and trabeculectomy in uveitic glaucoma. Eye 24(2):310–314CrossRefGoogle Scholar
  4. 4.
    Kaburaki T, Koshino T, Kawashima H et al (2009) Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye 23(7):1509–1517CrossRefGoogle Scholar
  5. 5.
    Ceballos EM, Beck AD, Lynn MJ (2002) Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 11(3):189–196CrossRefGoogle Scholar
  6. 6.
    Iwao K, Inatani M, Seto T et al (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma 23(2):88–94CrossRefGoogle Scholar
  7. 7.
    DeBry PW, Perkins TW, Heatley G et al (2002) Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 120(3):297–300CrossRefGoogle Scholar
  8. 8.
    Bindlish R, Condon GP, Schlosser JD et al (2002) Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 109(7):1336–1341CrossRefGoogle Scholar
  9. 9.
    Almobarak FA, Alharbi AH, Morales J et al (2016) Outcomes of trabeculectomy with mitomycin-C in uveitis associated with Vogt–Koyanagi–Harada disease. J Glaucoma 25(6):528–532CrossRefGoogle Scholar
  10. 10.
    Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32(3):149–170CrossRefGoogle Scholar
  11. 11.
    Broadway DC, Bates AK, Lightman SL et al (1993) The importance of cellular changes in the conjunctiva of patients with uveitic glaucoma undergoing trabeculectomy. Eye 7(Pt 4):495–501CrossRefGoogle Scholar
  12. 12.
    Jampel HD, Jabs DA, Quigley HA (1990) Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol 109(2):168–173CrossRefGoogle Scholar
  13. 13.
    Skuta GL, Beeson CC, Higginbotham EJ et al (1992) Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 99(3):438–444CrossRefGoogle Scholar
  14. 14.
    Katz GJ, Higginbotham EJ, Lichter PR et al (1995) Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology 102(9):1263–1269CrossRefGoogle Scholar
  15. 15.
    Kitazawa Y, Kawase K, Matsushita H et al (1991) Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 109(12):1693–1698CrossRefGoogle Scholar
  16. 16.
    Khaw PT, Sherwood MB, MacKay SL et al (1992) Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol 110(8):1150–1154CrossRefGoogle Scholar
  17. 17.
    Khaw PT, Doyle JW, Sherwood MB et al (1993) Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 111(2):263–267CrossRefGoogle Scholar
  18. 18.
    Lama PJ, Fechtner RD (2003) Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 48(3):314–346CrossRefGoogle Scholar
  19. 19.
    Reibaldi A, Uva MG, Longo A (2008) Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-c in primary open-angle glaucoma. Br J Ophthalmol 92(12):1666–1670CrossRefGoogle Scholar
  20. 20.
    Chen PP, Weaver YK, Budenz DL et al (1998) Trabeculectomy function after cataract extraction. Ophthalmology 105(10):1928–1935CrossRefGoogle Scholar
  21. 21.
    Ehrnrooth P, Lehto I, Puska P et al (2005) Phacoemulsification in trabeculectomized eyes. Acta Ophthalmol Scand 83(5):561–566CrossRefGoogle Scholar
  22. 22.
    Ozkiris A, Tamcelik N (2005) Long-term results of trabeculectomy with different concentrations of mitomycin C in refractory developmental glaucoma. J Ped Ophthalmol Strabismus 42(2):97–102Google Scholar
  23. 23.
    Shigeeda T, Tomidokoro A, Chen YN et al (2006) Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients. J Glaucoma 15(3):195–199CrossRefGoogle Scholar
  24. 24.
    Belyea DA, Dan JA, Stamper RL et al (1997) Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol 124(1):40–45CrossRefGoogle Scholar
  25. 25.
    Sung VC, Barton K (2004) Management of inflammatory glaucomas. Curr Opin Ophthalmol 15(2):136–140CrossRefGoogle Scholar
  26. 26.
    Molteno AC, Bosma NJ, Kittelson JM (1999) Otago glaucoma surgery outcome study: long-term results of trabeculectomy–1976 to 1995. Ophthalmology 106(9):1742–1750CrossRefGoogle Scholar
  27. 27.
    Almobarak FA, Alharbi AH, Morales J et al (2017) Intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma. J Glaucoma 26(5):478–485CrossRefGoogle Scholar
  28. 28.
    Yalvac IS, Sungur G, Turhan E et al (2004) Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behcet disease. J Glaucoma 13(6):450–453CrossRefGoogle Scholar
  29. 29.
    Almobarak FA, Alharbi AH, Morales J et al (2017) The influence of phacoemulsification on intraocular pressure control and trabeculectomy survival in uveitic glaucoma. J Glaucoma 26(5):444–449CrossRefGoogle Scholar
  30. 30.
    Prata JA Jr, Neves RA, Minckler DS et al (1994) Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Ophthalmic Surg 25(9):616–620PubMedGoogle Scholar
  31. 31.
    Law SK, Shih K, Tran DH et al (2009) Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. Am J Ophthalmol 148(5):685–695CrossRefGoogle Scholar
  32. 32.
    Carreno E, Villaron S, Portero A et al (2011) Surgical outcomes of uveitic glaucoma. J Ophthalmic Inflamm Infect 1(2):43–53CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  • Faisal A. Almobarak
    • 1
    • 2
    Email author
  • Ali H. Alharbi
    • 2
    • 3
  • Jose Morales
    • 2
  • Ibrahim Aljadaan
    • 2
  1. 1.Department of Ophthalmology, College of MedicineKing Saud UniversityRiyadhSaudi Arabia
  2. 2.Glaucoma DivisionKing Khaled Eye Specialist HospitalRiyadhSaudi Arabia
  3. 3.King Abdullah Medical CityMakkahSaudi Arabia

Personalised recommendations